May 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountpharmagradepeptides.com
Global Rank
- -
Country Rank
- -
Category Rank
- -
Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
31.85%
Pages per Visit
4.06
Avg Visit Duration
00:02:03
- Company
- - -
- Industry
- - -
Top 10 pharmagradepeptides.com Competitors
The Top 10 Sites Like pharmagradepeptides.com in May 2026 are ranked by their affinity to pharmagradepeptides.com in terms of keyword traffic, audience targeting, and market overlap
- Company
- - -
- Industry
- - -
Global Rank
#181,620
13,925Bounce Rate
32.91%
Pages per Visit
6.46
Avg Visit Duration
00:04:48
Similarity Score
100%High-purity AICAR peptides from Pura Peptides for scientific research. Reliable for lab testing and controlled research use
- Company
- - -
- Industry
- - -
Global Rank
#410,183
8,390Bounce Rate
39.95%
Pages per Visit
4.16
Avg Visit Duration
00:01:32
Similarity Score
83%buy peptides for scientific research and development. peptide sciences™ specializes in the synthesis of highly purified peptides, proteins and amino acid derivatives for scientific research and development.
- Company
- - -
- Industry
- - -
Global Rank
#824,620
350,714Bounce Rate
66.3%
Pages per Visit
1.42
Avg Visit Duration
00:00:12
Similarity Score
34%pharmagradepeptides.com's top 5 competitors in May 2026 are: nexaph.com, purapeptides.com, peptidesciences.com, , and more.
According to Similarweb data of monthly visits, pharmagradepeptides.com’s top competitor in May 2026 is nexaph.com. pharmagradepeptides.com 2nd most similar site is purapeptides.com, and closing off the top 3 is peptidesciences.com.
ranks as the 4th most similar website to pharmagradepeptides.com and ranks fifth in May 2026.
The other five competitors in the top 10 list are , , , , and .